Insider · CIK 0001699848

Valle Franco

Reports to the SEC for 3 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001699848

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-11-30	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+495 sh	$6.15	+$3,046.23	42,995
2024-06-11	BMEABiomea Fusion, Inc.P Purchase	Chief Financial Officer	PPurchase	+12.5K sh	$4.43	+$55.4K	42,500
2024-05-31	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+4,448 sh	$3.78	+$16.8K	29,991
2024-01-17	BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+145K sh	—	—	145,245
2023-11-30	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+1,345 sh	$3.78	+$5,087.463	25,543
2023-05-31	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+4,273 sh	$3.78	+$16.2K	24,198
2023-01-06	BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+126K sh	—	—	126,300
2022-11-30	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+2,518 sh	$3.78	+$9,524.335	19,925
2022-11-11	BMEABiomea Fusion, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,100 sh	$7.63	+$31.3K	17,407
2022-05-31	BMEABiomea Fusion, Inc.A Award	Chief Financial Officer	AAward	+3,307 sh	$4.67	+$15.4K	13,307
2022-01-14	BMEABiomea Fusion, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$8.68	+$86.8K	10,000
2021-12-04	BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+145K sh	—	—	144,770
2021-08-03	BMEABiomea Fusion, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+165K sh	—	—	165,000
2021-01-26	Eidos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−24.4K sh	—	—	0
2021-01-12	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,747 sh	$7.24	+$12.6K	1,747
2021-01-12	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,747 sh	$125.44	−$219K	0
2021-01-12	Eidos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,747 sh	—	—	24,350
2021-01-11	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,500 sh	$7.24	+$10.9K	1,500
2021-01-11	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,500 sh	$125.61	−$188K	0
2021-01-11	Eidos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,500 sh	—	—	26,097
2020-11-09	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+1,623 sh	$7.24	+$11.8K	1,623
2020-11-09	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,623 sh	$74.93	−$122K	0
2020-11-09	Eidos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−1,623 sh	—	—	27,597
2020-10-08	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+5,199 sh	$7.24	+$37.6K	5,199
2020-10-08	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−5,199 sh	$74.85	−$389K	0
2020-10-08	Eidos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−5,199 sh	—	—	29,220
2020-10-07	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+5,000 sh	$7.24	+$36.2K	5,444
2020-10-07	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−5,444 sh	$75.08	−$409K	0
2020-10-07	Eidos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−5,000 sh	—	—	34,419
2020-05-31	Eidos Therapeutics, Inc.A Award	Senior Vice President, Finance	AAward	+444 sh	$41.57	+$18.5K	444
2020-04-20	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+2,000 sh	$7.24	+$14.5K	2,000
2020-04-20	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,000 sh	$49.79	−$99.6K	0
2020-04-20	Eidos Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−2,000 sh	—	—	39,419
2020-03-26	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+5,000 sh	$7.24	+$36.2K	5,000
2020-03-26	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−3,000 sh	$47.87	−$144K	2,000
2020-03-26	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,000 sh	$48.85	−$97.7K	0
2020-03-26	Eidos Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−5,000 sh	—	—	41,419
2020-03-02	Eidos Therapeutics, Inc.M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+3,000 sh	$7.24	+$21.7K	3,000
2020-03-02	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−2,000 sh	$51.96	−$104K	1,000
2020-03-02	Eidos Therapeutics, Inc.S Sale	Senior Vice President, Finance	SSale	−1,000 sh	$53.06	−$53.1K	0
2020-03-02	Eidos Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−3,000 sh	—	—	46,419

Recent filings

Accepted (ET)
Dec 24
Valle Franco0000950170-24-132253
SEC(opens sec.gov)
Jun 124
Valle Franco0000950170-24-072494
SEC(opens sec.gov)
Jan 184
Valle Franco0000950170-24-005416
SEC(opens sec.gov)
Dec 14
Valle Franco0000950170-23-067424
SEC(opens sec.gov)
Jun 24
Valle Franco0000950170-23-026142
SEC(opens sec.gov)
Jan 104
Valle Franco0000899243-23-001486
SEC(opens sec.gov)
Dec 24
Valle Franco0000899243-22-037438
SEC(opens sec.gov)
Nov 144
Valle Franco0000899243-22-035697
SEC(opens sec.gov)
Jun 14
Valle Franco0000899243-22-020517
SEC(opens sec.gov)
Jan 184
Valle Franco0000899243-22-002217
SEC(opens sec.gov)
Dec 74
Valle Franco0001567619-21-021720
SEC(opens sec.gov)
Aug 54
Valle Franco0001567619-21-014561
SEC(opens sec.gov)
Jan 284
Valle Franco0000899243-21-003651
SEC(opens sec.gov)
Jan 134
Valle Franco0000899243-21-001847
SEC(opens sec.gov)

Companies

Address

999 SKYWAY ROAD, SUITE 150

SAN CARLOS, CA, 94070